Somerset Pharma — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Somerset Pharma is a private, commercial-stage generic drug company focused on manufacturing and supplying affordable generic medicines. The company leverages a robust intellectual property pipeline and state-of-the-art manufacturing, including a sterile products facility in India, to deliver a wide range of products. Led by a veteran management team with deep industry experience, Somerset aims to compete in the generic pharmaceutical market by emphasizing quality, innovation, and cost-effectiveness. Its strategy involves expanding its product portfolio and strengthening partnerships within the healthcare supply chain.

Broad Generic Portfolio

Technology Platform

Generic drug formulation development, bioequivalence testing, ANDA submission, and sterile manufacturing capabilities.

FDA Approved Drugs

1

EMSAMNDAFeb 27, 2006

Opportunities

The growing demand for affordable generics, especially in complex segments like sterile injectables, presents a significant opportunity.

Successfully leveraging its USFDA-approved manufacturing facility in India can provide a cost and scale advantage.

Expanding its portfolio through ANDA approvals in less competitive therapeutic niches can drive growth and improve margins.

Risk Factors

The company faces intense price competition and chronic price erosion in the generic drug market.

Regulatory compliance risks are high, as any failure at its manufacturing facilities could lead to severe disruptions.

Dependency on a global supply chain for APIs and potential patent litigation from brand-name companies also pose significant threats.

Competitive Landscape

Somerset Pharma competes in the highly fragmented and competitive generic pharmaceutical market against large players like Teva, Sandoz (Novartis), and Mylan (Viatris), as well as numerous smaller specialty generics companies. Its differentiation is based on a focus on quality, a veteran management team, and capabilities in sterile manufacturing, aiming to compete in more complex product categories with higher barriers to entry.

More companies in Small Molecule Drugs →More companies in United States →